AUG 16, 2020 1:29 PM PDT

Could Cat Drugs Treat COVID-19 in Humans?

WRITTEN BY: Annie Lennon

While COVID-19 may not affect cats much, felines are known to contract another kind of coronavirus that can sometimes be fatal. Now, early research has shown that the same drugs that can be used on cats to treat this disease may also help people suffering from COVID-19. 

The virus they treat in cats, known as ‘feline enteric coronavirus’ (FeCV) affects the gastrointestinal tract. While it rarely causes symptoms, in about one in 10% of cats, it mutates after infection and begins to infiltrate immune cells where it then causes havoc in the body and sets off severe inflammation. At this point, the infection is called ‘feline infectious peritonitis virus’ and is often fatal if left untreated. 

In lab experiments, researchers found that one drug, known as GC376, disables an enzyme that some coronaviruses use to replicate- including SARS-CoV-2. Based on these findings, and the fact that the drug has already been shown as safe and effective in cats, the company behind the drug, Anivive Lifesciences, is now working to develop clinical trials in people. 

Meanwhile, the other drug known to be effective in cats, called GS-441524, is an antiviral cousin of remdesivir, a drug known to accelerate recovery times in people suffering from COVID-19. Similar in structure, remdesivir differs from GS-441524 as it has an extra part that better enables it to enter cells. 

In a study in 2018, researchers demonstrated that GS-441524 not only inhibited viral replication in lab-grown cells but also successfully treated 10 out of 10 cats with feline infectious peritonitis virus. In a separate study from 2019, researchers then showed that treatment with the drug for at least 12 weeks left 25 out of 26 cats surviving the disease.

In July this year, a study also found the same drug was able to inhibit SARS-CoV-2 replication in lab-grown monkey and human cells. However, while remdesivir is already on its way to full FDA approval, GS-441524 has yet to be trialed in humans. Nevertheless, Gilead, the company behind both this drug and remdesivir has said it has begun preclinical studies to compare the drugs. 

Although it is still unknown whether GS-441524 or GC376 will be effective in humans against COVID-19, the drugs exemplify the connections between animal and human health, and how knowledge of both, could accelerate the finding of treatments in either species.  

 

Sources: Science NewsLive Science

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 02, 2020
Drug Discovery & Development
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
NOV 02, 2020
Beetroot Peptide Shows Promise in Treating Inflammatory Diseases
Researchers from the Medical Univesity of Vienna in Austria have found that a peptide (a small protein molecule) found i ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 17, 2020
Drug Discovery & Development
Antibiotics Before Age 2 Linked to Childhood Health Conditions
NOV 17, 2020
Antibiotics Before Age 2 Linked to Childhood Health Conditions
Researchers from Mayo Clinic have found a link between children aged two and under taking antibiotics and an increased r ...
NOV 20, 2020
Drug Discovery & Development
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
NOV 20, 2020
Cat Parasite Gives Clues on New Drug Targets for Schizophrenia
Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii  ...
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
Loading Comments...